TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says November 28, 2014